News
Twitter
Videos
Images
Events
News For Placebo
Convidicea Vaccine (Ad5-nCoV) - PrecisionVaccinations
Convidicea Vaccine (Ad5-nCoV)
PrecisionVaccinations
Google
1/18/2021 11:11:00 AM
Everest Medicines Announces Amended Agreement with Spero Therapeutics - BioSpace
Everest Medicines Announces Amended Agreement with Spero Therapeutics
BioSpace
Google
1/18/2021 11:00:43 AM
Management of non-alcoholic fatty liver disease - The BMJ
Management of non-alcoholic fatty liver disease
The BMJ
Google
1/18/2021 10:52:44 AM
LXRX Stock Price Increased By 78.21% This Past Week: Why It Happened - Pulse 2.0
LXRX Stock Price Increased By 78.21% This Past Week: Why It Happened
Pulse 2.0
Google
1/18/2021 8:51:03 AM
The search for effective drug treatments for COVID-19 - PMLiVE
The search for effective drug treatments for COVID-19
PMLiVE
Google
1/18/2021 8:44:27 AM
A Randomized, Placebo-Controlled Phase II Clinical Trial of 0.01% or 0.02% Cyclosporin A with 3% Trehalose in Patients with Dry Eye Disease. - Physician's Weekly
A Randomized, Placebo-Controlled Phase II Clinical Trial of 0.01% or 0.02% Cyclosporin A with 3% Trehalose in Patients with Dry Eye Disease.
Physician's Weekly
Google
1/18/2021 6:07:09 AM
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase 3 trial. - Physician's Weekly
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase 3 trial.
Physician's Weekly
Google
1/18/2021 5:22:54 AM
Second-Line Pembrolizumab Shows Continued OS and PFS Improvement in Advanced HCC - Targeted Oncology
Second-Line Pembrolizumab Shows Continued OS and PFS Improvement in Advanced HCC
Targeted Oncology
Google
1/18/2021 1:30:02 AM
1
2
3
4
5
...